Quick Answer
LB PHARMACEUTICALS INC reported Stockholders Equity of $301.31 million for fiscal year 2025.
LB PHARMACEUTICALS INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $301.31M | +418.7% |
| 2024 | -$94.55M | -174.3% |
| 2023 | -$34.47M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $310.22M | +439.2% | +398.7% |
| June 30, 2025 | -$103.87M | -34.1% | -4.6% |
| March 31, 2025 | -$99.34M | -96.9% | -5.1% |
| December 31, 2024 | -$94.55M | -174.3% | -3.4% |
| September 30, 2024 | -$91.45M | — | -18.1% |
| June 30, 2024 | -$77.44M | — | -53.5% |
| March 31, 2024 | -$50.45M | — | -46.3% |
| December 31, 2023 | -$34.47M | — | — |
- LB PHARMACEUTICALS INC showed an increase of +418.7% in Stockholders Equity compared to the prior fiscal year.
- Over the 2023–2025 period, LB PHARMACEUTICALS INC’s stockholders equity has grown by 974.0% (from -$34.47 million to $301.31 million).
- The most recent figure is from LB PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: